International Journal of Drug Delivery Technology
Volume 14, Issue 3

Design, Development and Characterization of Nisoldipine Solid Lipid Nanoparticles: Statistical and Characterization Perspectives

Neeraj Kumar Chauhan, Anuj Malik*

MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India. 

Received: 06th January, 2024; Revised: 03rd March, 2024; Accepted: 11thJuly, 2024; Available Online: 25th September, 2024 

ABSTRACT

The objective of this study was to develop and characterize solid lipid nanoparticles (SLNs) loaded with Nisoldipine (NIS), aiming to enhance the drug’s bioavailability and provide a sustained release profile. SLNs were prepared using a solvent evaporation method and evaluated for several critical parameters. The superfluity test assessed the homogeneity of the SLN suspension, while particle size, drug entrapment efficiency, shapes, and surface morphology were analyzed using SEM/DLS/ TEM. Researchers studied the process of how drugs are released and performed in-vitro drug release tests to establish the substance’s release profile. HPLC and FT-IR were used to verify the drug’s chemical stability and encapsulation effectiveness. Stability studies assessed the formulation’s stability over time throughout different storage settings.

The SLNs exhibited a high degree of homogeneity in the superfluity test, with no phase separation. The drug entrapment effectiveness was over 80%, and the typical particle size was 150-250 nm. Microscopy and transmission electron microscopy revealed that the SLNs had a flat, spherical top. NIS exhibited a regulated sequence of kinematics and prolonged release during dissolution investigations. FTIR and HPLC confirmed the stability and integrity of the drug within the SLNs. Stability studies indicated that the formulation remained stable over time.

NIS-loaded SLNs show significant potential as an effective drug delivery system, offering enhanced bioavailability, sustained

release, and excellent stability.

Keywords: Solid lipid nanoparticles, Nisoldipine, Drug delivery, Sustained release, Nanoparticles, Bioavailability.

International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.3.53

How to cite this article: Chauhan NK, Malik A. Design, Development and Characterization of Nisoldipine Solid Lipid Nanoparticles: Statistical and Characterization Perspectives. International Journal of Drug DeliveryTechnology. 2024;14(3):1623-1634.

REFERENCES

  1. Gupta S, Sharma S, Minocha N. Nisoldipine: A review of its pharmacology, pharmacokinetics, and therapeutic efficacy in hypertension management. Current Hypertension Reports. 2016;18(7):49.
  2. Zhang H, Liu F, Gao C, Cui Y, Wei W. Improving the oral bioavailability of nisoldipine by nanocrystal formulation: In-vitro and in vivo evaluation. Journal of Pharmaceutical Sciences. 2014;103(6):1848-1856.
  3. Erle G, Sinico C, Manca ML, Lai F, Valenti D, Fadda AM. Incorporation of nisoldipine in lipid nanoparticles: Preparation, characterization and in-vitro International Journal of Pharmaceutics. 2013;450(1-2):69-76.
  4. Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente JM, Grazú V, Borm P, Estrada G, Ntziachristos V, Razansky D. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Particle and fibre toxicology. 2010;7:1-25. https://doi.org/10.1186/1743-8977-7-3
  5. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced drug delivery reviews. 2002;54:S131-155. https://doi.org/10.1016/S0169- 409X(02)00118-7
  6. Mehnert W, Mäder K. Solid lipid nanoparticles: production, character i zation and Advanced d r ug delivery reviews. 2012;64:83-101. https://doi.org/10.1016/j. addr.2012.09.021
  7. Beloqui A, Solinís MA, Delgado A, Evora C, Sánchez-Esparza J, Wilhelm Solid lipid nanoparticles: promising drug delivery systems for future clinics. Nanomedicine. 2016;12(1):143-161.
  8. Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian journal of pharmaceutical sciences. 2009;71(4):349. https://doi. org/10.4103%2F0250-474X.57282
  9. Attama AA, Reichl S, Müller- Goymann Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea. Current eye research. 2009;34(8):698-705. https://doi. org/10.1080/02713680903017500
  10. Jain SK, Chourasia MK, Jain AK, Jain RK, Jain D, Chalasani Design and development of multivesicular liposomes (MVLs) for controlled and targeted drug delivery of nitrofurantoin in the treatment of urinary tract infection. Drug Delivery. 2006;13(6):383-389.
  11. Puglia C, Bonina Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opinion on Drug Delivery. 2012;9(4):429-441. https://doi.org/10.1517/17425 247.2012.666967
  12. Nayak AP, Tiyaboonchai Mucoadhesive oral delivery of nisoldipine-loaded nanostructured lipid carriers. AAPS PharmSciTech. 2015;16(3):533-542.
  13. Garbayo E, Ansorena E, Blanco-Prieto MJ. Drug development in Parkinson’s disease: from emerging molecules to innovative drug delivery systems. Maturitas. 2013;76(3):272-278. https:// org/10.1016/j.maturitas.2013.05.019
  14. Yadav P, Soni G, Mahor A, Alok S, Singh PP, Verma Solid lipid nanoparticles: an effective and promising drug delivery system-A review. International Journal of Pharmaceutical Sciences and Research. 2014;5(4):1152-1162.
  15. Amrutiya N, Bajaj A, Madan Development of microsponges for topical delivery of mupirocin. Aaps Pharmscitech. 2009;10:402-409.
  16. Wissing SA, Müller RH. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. International journal of pharmaceutics. 2002;242(1-2):377-379.
  17. Sharma A, Jindal S, Rohilla S, Haque Solid lipid nanoparticles: A promising drug delivery technology for poorly water-soluble drugs. Acta Pharm Sin B. 2021;11(6):1218-1238.
  18. Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to Critical Reviews™ in Therapeutic Drug Carrier Systems. 2009;26(6):523-580. DOI: 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10
  19. Hu L, Xing Q, Meng J, Shang C, Song D, Zhao Y. Solid lipid nanoparticles of temozolomide: effects of the lipid matrix and loading drug on in-vitro release behavior. Drug Development and Industrial Pharmacy. 2014;40(7):937-944.
  20. Doktorovova S, Souto EB. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive Expert opinion on drug delivery. 2009;6(2):165-176. https://doi. org/10.1517/17425240802712590
  21. Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal Advanced drug delivery reviews. 2007;59(6):522-530. https://doi.org/10.1016/j. addr.2007.04.012
  22. Haider M, Abdin SM, Kamal L, Orive Nanostructured lipid carriers for delivery of chemotherapeutics: A review. Pharmaceutics. 2020;12(3):288. https://doi.org/10.3390/ pharmaceutics12030288
  23. Prabhakaran E, Hasan A, Karunanidhi P. Solid lipid nanoparticles: A review. Scientific Reviews & Chemical Communications. 2012;2:80-102.
  24. Khan S, Baboota S, Ali J, Khan S, Narang RS, Narang JK. Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs. International journal of pharmaceutical 2015 Oct;5(4):182-191. https://doi.org/10.4103%2F2230-973X.167661
  25. Vivek K, Reddy H, Murthy Investigations of the effect of the lipid matrix on drug entrapment, in-vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. Aaps Pharmscitech. 2007;8:16-24. https://doi.org/10.1208/pt0804083
  26. Ali MS, Ahmad J, Ali M, Warsi MH, Baboota Recent advances in topical nanoemulsions as drug delivery systems: a review. Current Drug Delivery. 2013;10(2):254-268.
  27. Aditya NP, Shim M, Lee I, Lee Y, Im MH, Ko S. Curcumin and dexibuprofen loaded nanostructured lipid carriers: formulation and characterization. Journal of Nanoscience and Nanotechnology. 2012;12(9):8411-8417.
  28. Khan M, Sadia H, Khan M, Bafakeeh O, Khedher N, Mahdi Development and characterization of solid lipid nanoparticles for the delivery of ascorbic acid: A comprehensive study. AAPSPharmSciTech. 2020;21(4):126.
  29. Dufresne M, Nanoshel V, Dufresne A. Techniques for the characterization of In: Nanoparticles in Medicine: Synthesis, Characterization, and Applications. Cham: Springer; 2018. p. 67-87.
  30. Ghorbani M, Ramezani Z, Baghery Solid lipid nanoparticles: A comprehensive review on the development and applications. Advanced pharmaceutical bulletin. 2019;9(1):8-20.
  31. Singh S, Sinha V, Madaan J, Choudhury Characterization of solid lipid nanoparticles: A comprehensive review. International Journal of Pharmaceutics. 2018;548(1):208-17.
  32. Zhang Y, Yang Z, Wu Q, Huang S, Zhang In-vitro and in vivo studies of solid lipid nanoparticles loaded with an antiviral drug for the treatment of viral infections. Drug Development and Industrial Pharmacy. 2019;45(4):547-55.
  33. Costa P, Lobo Modeling and comparison of dissolution profiles. European journal of pharmaceutical sciences. 2001;13(2):123-133. https://doi.org/10.1016/S0928-0987(01)00095-1
  34. Jadhav M, Bhise K, Chavan R, Mohan Application of Fourier- transform infrared spectroscopy (FTIR) for the characterization of herbal formulations. Journal of Pharmacy and Bioallied Sciences. 2015;7(4):375-382.
  35. Bhaskar S, Saraf S, Saraf S. Role of HPLC in the estimation of pharmaceuticals: A Journal of Pharmaceutical Research. 2012;5(6):2802-2806.
  36. Pooja S, Gupta D, Awasthi R, Mishra A. Stability testing of pharmaceutical products: A comprehensive J Pharm Sci Res. 2018;10(1):193-198.
  37. Devhare LD and Gokhale Antioxidant and Antiulcer Property of Different Solvent Extracts of Cassia Tora Linn. Research Journal of Pharmacy and Technology. 2022;15(3);1109-1113. http://dx.doi.org/10.52711/0974-360X.2022.00185.
  38. Tiwari R, Mishra J, Devhare LD and Tiwari An updated review on recent developments and applications of fish collagen. Pharma Times. 2023;55(6):28-36
  39. Adimulapu AK, Devhare LD, Anasuya Patil A, Chachda NO,Dharmamoorthy. Design and Development of Novel Mini Tablet Cap Technology for the Treatment of Cardiovascular Diseases. International Journal of Drug Delivery Technology. 2023;13(3):801-806. DOI: 10.25258/ijddt.13.3.04
  40. Chawla A, Devhare LD, Dharmamoorthy G, Ritika, Tyagi S. Synthesis and In-vivo Anticancer Evaluation of N-(4-oxo-2- (4-((5-aryl-1,3,4 thiadiazole-2yl) amino) Phenyl thiazolidine-3-yl) Benzamide derivative. International Journal of PharmaceuticalQuality Assurance. 2023;14(3):470- 474. DOI: 10.25258/ijpqa.14.3.02.
  41. Gnana RPM, Devhare LD, Dharmamoorthy G, Khairnar MV, Prasidha R. Synthesis, Characterisation, Molecular Docking Studies and Biological Evaluation of Novel Benzothiazole Derivatives as EGFR Inhibitors for Anti-breast Cancer Agents. International Journal of Pharmaceutical Quality Assurance. 2023;14(3):475-480. DOI: 10.25258/ijpqa.14.3.03.
  42. Sonule M, Devhare LD, Babu MN, Gunjal SD, Varalaxmi S. Microemulgel-based Hydrogel of Diclofenac Sodium using Lipidium sativum as a Gelling Agent. International Journal of Drug Delivery 2023;13(4):1235-1239. DOI: 10.25258/ ijddt.13.4.19
  43. Shriram BK, Devhare LD, Mehrotra A, Deokar SS, Singh SP. Formulation and Evaluation of Mosquito Repellent International Journal of Drug Delivery Technology. 2023;13(4):1283-1286.
  44. Choudhary RK, Beeraka S, Sarkar BK, Dharmamoorthy G, Devhare L. Optimizing Verapamil Hydrochloride In-situ Delivery: A Strategic Formulation Approach using Box- Behnken Design for Enhanced Performance and Comprehensive Evaluation of Formulation Parameters. International Journal of Drug Delivery Technology. 2024;14(1):61-70. DOI: 10.25258/ 14.1.11
  45. Kumar KK, Kiran V, Choudhary RK, Devhare LD, Gunjal SD. Design Development and Characterization of Nicardipine Solid Lipid Nano-Particulars. International Journal of Drug Delivery Technology. 2024;14(1):71-78. DOI: 25258/ijddt.14.1.12
  46. Priya MGR, Prasanth LML, Devhare LD, Yazdan SK, Gunjal S. Synthesis, DNA Binding, Molecular Docking and Anticancer Studies of Copper (II), Nickel (II), and Zinc (II) Complexes of Primaquine-based Ligand. International Journal of Pharmaceutical Quality Assurance. 2024;15(1):69-75. DOI: 25258/ijpqa.15.1.10
  47. Uplanchiwar VP, Raut SY, Devhare LD, et Pharmacological Assessment of Antiulcer Activity of Gloriosa Superba Linn Tubers In Experimentally Induced Gastric Ulcers. Journal of Medical Pharmaceutical and Allied Science. 2021;10(3);2852- 2856.
  48. Tiwari G, Gupta M, Devhare LD, Tiwari R. Therapeutic and Phytochemical Properties of Thymoquinone Derived from Nigella Sativa. Current Drug Research Reviews Formerly: Current Drug Abuse Reviews. 2024;16(2):145-156. https://doi. org/10.2174/2589977515666230811092410.